ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Ketamine Offers Hope for OCD Patients as Alternative to Traditional Medication

Monroe, MI (Newsworthy.ai) Thursday Apr 27, 2023 @ 6:00 PM Central —

Ketamine is increasingly recognized as a promising treatment for those suffering from obsessive-compulsive disorder (OCD). With its ability to act on receptor sites in the brain, ketamine offers hope for those individuals who have not seen success with traditional medication.

Ketamine has shown great promise in treating OCD symptoms by lifting the blockade that helps OCD symptoms develop and inhibits their progression. Ketamine also increases the levels of serotonin and dopamine receptors, which induces feelings of relaxation and relief from obsessive thoughts and behaviors."

Studies have shown that ketamine can reduce intrusive thoughts quickly, with many individuals experiencing positive results within hours of receiving a dose. In some cases, positive effects have lasted up to fourteen days after administration.

My K Blend knows that the use of ketamine in the treatment of OCD is a promising development and that ketamine therapy represents hope for many people experiencing OCD symptoms.

About My K Blend

At K Blend, our experts will listen to your story. We will understand you. This relationship allows you to feel comfortable throughout the process and focus on healing.

Once you feel safe to heal, you can be honest. We don’t force you to wear a fake smile or pretend to be someone. Here, we are real, support you at your weakest, and lead you to hope, healing, and health.



This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.